ESPR
Esperion Therapeutics Inc.

9,364
Mkt Cap
$896.73M
Volume
3.88M
52W High
$4.13
52W Low
$0.6925
PE Ratio
-6.94
ESPR Fundamentals
Price
$3.84
Prev Close
$3.72
Open
$3.73
50D MA
$3.42
Beta
1.11
Avg. Volume
5.13M
EPS (Annual)
-$0.2764
P/B
-1.69
Rev/Employee
$1.09M
Loading...
Loading...
News
all
press releases
Esperion Therapeutics (NASDAQ:ESPR) Upgraded by Wall Street Zen to "Buy" Rating
Wall Street Zen upgraded shares of Esperion Therapeutics from a "hold" rating to a "buy" rating in a research note on Saturday...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Up - What's Next?
Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Up - What's Next...
MarketBeat·5d ago
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Shares Down 4.8% - Time to Sell?
Esperion Therapeutics (NASDAQ:ESPR) Shares Down 4.8% - Here's What Happened...
MarketBeat·8d ago
News Placeholder
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Brokerages
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) have earned an average rating of "Moderate Buy" from the eight research firms that are covering the stock, MarketBeat reports...
MarketBeat·11d ago
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Hits New 52-Week High - Time to Buy?
Esperion Therapeutics (NASDAQ:ESPR) Reaches New 1-Year High - What's Next...
MarketBeat·15d ago
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) General Counsel Sells $23,917.39 in Stock
Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) General Counsel Benjamin Looker sold 6,517 shares of Esperion Therapeutics stock in a transaction dated Wednesday, December 17th. The...
MarketBeat·20d ago
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) CFO Benjamin Halladay Sells 7,337 Shares
Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) CFO Benjamin Halladay sold 7,337 shares of Esperion Therapeutics stock in a transaction dated Wednesday, December 17th. The stock was sold...
MarketBeat·20d ago
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Sets New 12-Month High - Should You Buy?
Esperion Therapeutics (NASDAQ:ESPR) Hits New 12-Month High - Here's Why...
MarketBeat·26d ago
News Placeholder
Two Seas Capital LP Raises Holdings in Esperion Therapeutics, Inc. $ESPR
Two Seas Capital LP raised its position in shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) by 43.6% in the second quarter, according to the company in its most recent Form 13F...
MarketBeat·1mo ago
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Hits New 52-Week High - Should You Buy?
Esperion Therapeutics (NASDAQ:ESPR) Hits New 1-Year High - Should You Buy...
MarketBeat·1mo ago
<
1
2
...
>

Latest ESPR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.